Navigation Links
United BioSource Corp. erweitert mit entscheidender Neubesetzung Potenzial in Europa
Date:2/7/2013

BLUE BELL, Pennsylvania, 7. Februar 2013 /PRNewswire/ -- Die United BioSource Corp. (UBC), eine Tochtergesellschaft von Express Scripts, erweitert ihre branchenführenden, pharmazeutischen Risikomanagement-Dienstleistungen in Europa. Biopharmazeutische Kunden mit Hauptsitz in Europa oder Kunden mit einer großen betrieblichen Präsenz auf dem Kontinent können damit besser von den Fachkenntnissen des US-Marktführers profitieren.

Janine Collins , MD, wird von ihrem Sitz in Genf (Schweiz) für die europäische Abteilung für Risikomanagement der UBC zuständig sein, die von Annette Stemhagen , Ärztin für öffentliche Gesundheit und Mitglied der International Society for Pharmacoepidemiology, ein führender Berater für Vorschriften und Programme zur Arzneimittelsicherheit in den Vereinigten Staaten, geleitet wird. Dr. Collins, Absolventin der St. George's Hospital Medical School in London, verfügt über Fachkenntnisse in den folgenden Bereichen:

  • Entwicklung europäischer Risikomanagement-Pläne und Strategien zur Risikominimierung, um regulatorischen Anforderungen gerecht zu werden
  • Konzeption und Umsetzung von nach der Zulassung angeordneten Sicherheitsstudien
  • Führende Risikomanagement-Programme für zwei teratogene Produkte, Revlimid und Thalidomid

Sean Hart , General Manager & Senior Vice President der UBC , erklärte: „Für die Anbieter von Risikomanagement- und Pharmakovigilanz-Dienstleistungen ist es wichtig, Erfahrung in der Arbeit mit den Zulassungsbehörden in jedem europäischen Land zu haben und die Feinheiten, die mit einer globalen Markteinführung einschlie&
'/>"/>

SOURCE Express Scripts
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
2. Student of Liver And Vascular Surgery of West China Hospital of Sichuan University Addresses The 18th ILTS Annual Meeting in the United States
3. Eleven Integrated Health Systems Form Largest Private-Sector Diabetes Registry in United States
4. United Spinal To "Roll on Capitol Hill:" Voices Aim to Impact Federal Health Care Policy
5. United States ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
6. Zimmer Introduces First Porous Metal Interbody Implant for Lumbar Spine in the United States
7. United Kingdom ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
8. United States Surgical Equipment Market Outlook to 2018- Electrosurgical Devices, Hand Instruments and Surgical Sutures
9. United States Market for Psoriatic Arthritis Pharmacotherapy
10. 2012 United States Medical Devices Outlook
11. Celladon Corporation Receives Patent from United States Patent and Trademark Office
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)...  Actavis plc (NYSE: ACT ) ... offerings of 14,513,889 Ordinary Shares at $288.00 per ... Series A, at $1,000.00 per share, each having ... The amounts sold include 1,319,444 Ordinary Shares and ... the exercise in full of the over-allotment option ...
(Date:3/2/2015)... N.J., March 2, 2015  IGI Laboratories, Inc. (NYSE MKT: ... its financial results for the fourth quarter and year ended ... Date 2014 Highlights , Total revenues of $13.7 ... 104% over the same quarter in 2013 , Total ... 2014, an increase of 85% over the same period in ...
(Date:3/2/2015)... Click here for additional information on the earnings results . ... the nation,s largest independent specialty pharmacy, announced financial results for ... unless otherwise noted, are to the quarter or year ended ... include: , Revenue of $612 million, an increase ... increase of 11% , Gross margin of 6.7% versus ...
Breaking Medicine Technology:Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 2Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 3Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 4Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 5Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 6Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 7Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 8IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 2IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 3IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 4IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 5IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 6IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 7IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 8IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 9IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 10IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 11IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 12Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 2Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 3Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 4Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 5Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 6Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 7Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 8Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 9Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 10Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 11Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 12Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 13Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 14Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 15Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 16Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 17Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 18
... ... ... ... , ...
... , ... ... ... ...
Cached Medicine Technology:MIT Changes Its Name to Micro Identification Technologies 2MIT Changes Its Name to Micro Identification Technologies 3MIT Changes Its Name to Micro Identification Technologies 4Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 2Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 3Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 4Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 5Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 6Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 7Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 8Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 9Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 10Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 11Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 12Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 13Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 14Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 15Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 16Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 17Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 18Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 19Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 20Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 21Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 22Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 23Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 24Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 25Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 26Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 27Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 28Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 29Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 30Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 31Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 32Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 33
(Date:3/2/2015)... USA (PRWEB) March 02, 2015 A ... newest scandal deviating from the typical nip slip or ... the movie industry is dawning the streets of Hollywood ... sparks questions about drug addiction and substance abuse in ... was constructed to take a political stance on the ...
(Date:3/2/2015)... FL (PRWEB) March 02, 2015 While ... with Title VI of the Civil Rights Act, the ... and hearing loss are bringing light to the value ... statistics reveal that nearly 1 in 20 U.S. children ... in 10 in some major cities.(1) Stratus Video ...
(Date:3/2/2015)... Robins & Morton Celebrates Women In ... in Construction Week (March 1-7, sponsored by the National ... Women’s History Month, Robins & Morton is recognizing several ... and the construction industry as a whole. From the ... of roles in between, each woman has a story ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Over the ... acquisitions among leading vendors seeking to expand their geographic ... market is expected to reach $6.2 billion by 2019 ... North America including the U.S. and Canada and a ... devices. However developing regions such as Asia-Pacific including China ...
(Date:3/2/2015)... Dinner preparation and meal planning ... success of DinnerDork , a company that ... for thousands of busy customers. The company recently ... to offer a total of 6 diverse meal ... classic recipes and comfort foods; Paleo Palette, which ...
Breaking Medicine News(10 mins):Health News:Oscar Statue Snorting Cocaine Catches All Eyes in Hollywood, Ca 2Health News:Oscar Statue Snorting Cocaine Catches All Eyes in Hollywood, Ca 3Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 2Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 3Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 4Health News:Robins & Morton Recognizes Women In Construction 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 3Health News:DinnerDork Announces New Meal Planning Support for the Home Cook 2Health News:DinnerDork Announces New Meal Planning Support for the Home Cook 3
... They,re young, brave and hopeful, battling the cancers that still ... with permanent neurological and other effects. They,re the children in ... a cure are former Eagle, Vince Papale, and a host ... May 4, for the 25th Eagles Fly for Leukemia Celebrity ...
... research published in the April issue of the ... that, among surgeons inexperienced in laparoscopic techniques, closing incisions ... learn and results in improved outcomes compared with suturing ... , Laparoscopic suturing a minimally invasive operation ...
... Foundation launches fourth phase of firefighter education program at ... providing innovative education programs to our nation,s fire service ... fourth installment of the To Hell and Back ... and Back IV: Cyanide takes participants inside the ...
... WASHINGTON, April 20 On April 15, 2009, ten members ... gathered in Washington, D.C. and attended more than a dozen ... visit was to raise awareness of transplant related issues on ... activities:, , ...
... by Sara and Susan G. Komen for the Cure, San Diego ... 20 Word is spreading about YOGA 4 THE CURE. ... together to stretch, deep breathe and meditate. Along with getting ... donations for breast cancer. Susan G. Komen for the Cure, San ...
... protection eludes those exposed as adolescents , , MONDAY, April ... they produce might help protect women from some of ... ingredient in marijuana, Louisiana State University researchers predict, based ... did not seem to apply, however, if the female ...
Cached Medicine News:Health News:Vince Papale and Eagles Fly for Leukemia Tee Up for a Cure at May 4, 2009 Celebrity Golf Classic and Auction 2Health News:Robot improves suture proficiency more rapidly for surgeons inexperienced in laparoscopic techniques 2Health News:Robot improves suture proficiency more rapidly for surgeons inexperienced in laparoscopic techniques 3Health News:Discover the Deadly Toxic Twins: Hydrogen Cyanide and Carbon Monoxide 2Health News:Discover the Deadly Toxic Twins: Hydrogen Cyanide and Carbon Monoxide 3Health News:Discover the Deadly Toxic Twins: Hydrogen Cyanide and Carbon Monoxide 4Health News:AST Leaders Fly to Capitol Hill to Garner and Secure Support for Transplantation Initiatives 2Health News:YOGA 4 THE CURE Raises $1,000 for Breast Cancer 2Health News:YOGA 4 THE CURE Raises $1,000 for Breast Cancer 3Health News:Estrogen May Combat Marijuana's Effect on Cognition 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: